CompletedPhase 3NCT02623556
Clinical Study of Recombinant Mycobacterium Tuberculosis ESAT6-CFP10 Allergen
Studying Tuberculosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
- Principal Investigator
- Shuihua Lu, BachelorShanghai Public Health Clinical Center
- Intervention
- ESAT6-CFP10 (10ug/ml) in left arm and TB-PPD in right arm(biological)
- Enrollment
- 1090 enrolled
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2015 – 2018
Study locations (2)
- Wuxi NO.5 People's Hospital, Wuxi, Jiangsu, China
- Shanghai Public Health clinical Center, Shanghai, Shanghai Municipality, China
Collaborators
Shanghai Public Health Clinical Center · Tianjin Haihe Hospital · Air Force Military Medical University, China · Proswell Medical Corporation · Wuhan Institute for Tuberculosis Control · Beijing Chest Hospital · Wuxi Hospital for Infectious Diseases · First Affiliated Hospital of Chongqing Medical University · Fuzhou Pulmonary Hospital of Fujian · Zhenjiang Third People's Hospital · Anhui Provincial Hospital · Shenzhen Third People's Hospital
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02623556 on ClinicalTrials.govOther trials for Tuberculosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07164742Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure)Johns Hopkins University
- RECRUITINGNCT0707721318F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis PatientsChildren's Hospital Medical Center, Cincinnati
- ENROLLING BY INVITATIONNANCT06984887Evaluation of New TB Diagnostic Tests (NATs) in PakistanMercy Corps Pakistan
- RECRUITINGNCT07018076Candidate Clinical Correlate of Prognostic Outcome for TB StudyUniversity of California, San Francisco
- RECRUITINGNANCT07271225Safety and Efficacy of Ear Acupuncture for Antituberculosis Drug-Related Nausea and VomitingIndonesia University
- RECRUITINGNCT06585358DoseTB-individualised Dosing by Model-informed Precision Dosing for Pulmonary TuberculosisKarolinska Institutet
- RECRUITINGPHASE3NCT06497465Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB TreatmentJohns Hopkins University
- RECRUITINGNCT07178860Respiratory Health and Wellbeing Post Pulmonary TuberculosisLiverpool School of Tropical Medicine